Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1289107
Max Phase: Preclinical
Molecular Formula: C16H12FNO3S
Molecular Weight: 317.34
Molecule Type: Small molecule
Associated Items:
ID: ALA1289107
Max Phase: Preclinical
Molecular Formula: C16H12FNO3S
Molecular Weight: 317.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS(=O)(=O)c1ccc(/C=C2/C(=O)Nc3ccc(F)cc32)cc1
Standard InChI: InChI=1S/C16H12FNO3S/c1-22(20,21)12-5-2-10(3-6-12)8-14-13-9-11(17)4-7-15(13)18-16(14)19/h2-9H,1H3,(H,18,19)/b14-8+
Standard InChI Key: CCFTYTAWQLACEE-RIYZIHGNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 317.34 | Molecular Weight (Monoisotopic): 317.0522 | AlogP: 2.72 | #Rotatable Bonds: 2 |
Polar Surface Area: 63.24 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.49 | CX Basic pKa: | CX LogP: 2.25 | CX LogD: 2.25 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.87 | Np Likeness Score: -1.19 |
1. Lai Y, Ma L, Huang W, Yu X, Zhang Y, Ji H, Tian J.. (2010) Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors., 20 (24): [PMID:21055929] [10.1016/j.bmcl.2010.10.056] |
Source(1):